CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Santen Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 31, 2022Atropine-Containing Aqueous Composition2
Jan 26, 2022Method And Composition For Treating Ocular Hypertension And Glaucoma3
Apr 29, 2020Method And Composition For Treating Ocular Hypertension And Glaucoma1
May 3, 2017Method And Composition For Treating Ocular Hypertension And Glaucoma1

Top competitors of Santen Pharmaceutical

List of top competitors of Santen Pharmaceutical based on patent oppositions.